[1] 王圆圆,陈柯羽,张青.基于“正邪学说”的肿瘤标本理论及临床应用[J].中医杂志,2013,54(21):1808-1811. Wang YY, Chen KY, Zhang Q. Tumor specimen theory based on “theory of vital qi and pathogenic qi” and its clinical application[J]. Journal of Traditional Chinese Medicine, 2013,54(21):1808-1811. [2] 刘清华,王璐璐.基于中医正邪学说关系浅析肿瘤免疫治疗的理论探讨[J].中医肿瘤学杂志,2019,1(1):8-11. Liu QH, Wang LL. A theoretical discussion on tumor immunotherapy based on the relationship between vital qi and pathogenic qi[J]. Journal of Oncology in Chinese Medicine, 20191,1(1):8-11. [3] 石翎笙,贺娟.《黄帝内经》“正气”概念内涵辨析[J].北京中医药大学学报,2020,43(6):469-474. Shi LS, He J. Analysis of the concept of “Zhengqi” in Huangdi Neijing[J]. Journal of Beijing University of Traditional Chinese Medicine, 2020,43(6):469-474. [4] 烟建华,张俐敏.《黄帝内经》“邪”概念内涵的学术解读[J].中华中医药杂志,2007,22(8):507-510. Yan JH, Zhang LM. Academic connotation of “pathogenic factors” in Huangdi Neijing[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2007,22(8):507-510. [5] 梁艳,陈子杰,王慧如,等.论《黄帝内经》治疗和养生中的正邪观[J].吉林中医药,2017,37(11):1089-1091. Liang Y, Chen ZJ, Wang HR, et al. Health qi and pathogenic qi in the treatment and health preservation of Internal Classic[J]. Jilin Journal of Chinese Medicine, 2017,37(11):1089-1091. [6] 陈钢.正邪关系补论[J].成都中医药大学学报,2005,28(1):1-3. Chen G. Supplementary discussion on the relationship between vital qi and pathogenic qi[J]. Journal of Chengdu University of TCM, 2005,28(1):1-3. [7] 刘俊杰,肖长江,李姿蓉,等.运用辩证法解析争议中的“和法”[J].北京中医药大学学报,2016,39(6):449-451. Liu JJ, Xiao CJ, Li ZR, et al. Using dialectics to discuss the controversial “harmonizing therapy”[J]. Journal of Beijing University of Traditional Chinese Medicine, 2016,39(6):449-451. [8] 莫秀云,何旭敏,詹乐昌.浅谈“以毒攻毒”蕴含的中医邪正统一关系[J].中医研究,2004,17(2):6-7. Mo XY, He XM, Zhan LC. Discussion on the unified relationship between vital qi and pathogenic qi of traditional Chinese medicine in “combatting poison with poison”[J]. Traditional Chinese Medicinal Research, 2004,17(2):6-7. [9] 李晨旭,孟丹华,陈玉龙.陈玉龙谈恶气与肿瘤[J].中医药导报,2019,25(20):19-21,28. Li CX, Meng DH, Chen YL. CHEN Yu-long Talks about Un-Vital qi and tumor[J]. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 2019,25(20):19-21,28. [10] 陈玉龙,司富春,王庆其.恶气与肿瘤病机关系探讨[J].河南中医学院学报,2004,19(6):9-11. Chen YL, Si FC, Wang QQ. Pathogenic factors and pathogenesis of tumor[J]. Journal of Henan University of Chinese Medicine, 2004,19(6):9-11. [11] 王书杰,张永琴,韦艾凌.浅论痰瘀在原发性肝癌发生、发展及转移中的作用[J].中国中医基础医学杂志,2012,18(9):957-958,961. Wang SJ, Zhang YQ, Wei AL. Discussion on the role of phlegm and blood stasis in primary hepatocellular carcinoma occurrence, development and metastasis[J]. Journal of Basic Chinese Medicine, 2012,18(9):957-958,961. [12] 邹子骅,李峻岭.肿瘤微环境的理论及治疗进展[J].癌症进展,2019,17(23):2737-2740,2780. Zou ZH, Li JL. Theories and treatment progress of tumor microenvironment[J]. Oncology Progress,2019,17(23):2737-2740,2780. [13] Kim K, Sohn YJ, Lee R, et al. Cancer-associated fibroblasts differentiated by exosomes isolated from cancer cells promote cancer cell invasion[J/OL]. Int J Mol Sci, 2020(21):8153 [2020-08-07]. https://doi.org/10.3390/ijms21218153. [14] 张超,王晓林,李晨辉,等.肿瘤与免疫细胞通过外泌体相互作用的研究进展[J].肿瘤学杂志,2020,26(6):469-474. Zhang C, Wang XL, Li CH, et al. Research progress on the interaction between tumor and immune cells through exosomes[J]. Journal of Chinese Oncology, 2020,26(6):469-474. [15] 顾军花,刘嘉湘.刘嘉湘教授“扶正治癌”理论核心及运用方法[J].中国中西医结合杂志,2017,37(4):495-499. Gu JH, Liu JX. Core theory and application of Professor Liu Jiaxiang's theory on “strengthening vital qi to treat cancer”[J]. Chinese Journal of Integrated Traditional and Western Medicine, 2017,37(4):495-499. [16] 李黎,周雍明,朴炳奎.朴炳奎治疗恶性肿瘤“和其不和”学术思想探究[J].中国中医药图书情报杂志,2018,42(3):67-69. Li L, Zhou YM, Piao BK. Research on Piao Bing-kui's academic thoughts of malignant tumor treatment by “regulating the imbalance of the body”[J]. Chinese Journal of Library and Information Science for Traditional Chinese Medicine, 2018,42(3):67-69. [17] 李惠惠,李全富.扶正解毒方对小鼠前胃癌诱导肿瘤相关巨噬细胞的影响[J].吉林中医药,2016,36(9):922-925. Li HH, Li QF. Centralizer detoxification treatment of mice induced by gastric cancer before cancer research[J]. Jilin Journal of Chinese Medicine, 2016,36(9):922-925. [18] 黎金华,田菲,邱崇笙,等.扶正散结方调控Lewis肺癌小鼠TAMs免疫重塑作用的相关研究[J].中国中药杂志,2015,40(6):1161-1165. Li JH, Tian F, Qiu CS, et al. Relevant studies on effect of Fuzheng Sanjie recipe in regulating immune microenvironment remodeling of TAMs in lewis lung cancer mice[J]. China Journal of Chinese Materia Medica, 2015,40(6):1161-1165. [19] 苏乐. 健脾化瘀方通过miRNA-570调控B7-H1/PD-1通路防治肝癌术后复发的体内机制[D].广州:广州中医药大学,2017. Su L. Preventive and therapeutic effect of Jianpi Huayu decoction on postoperative recurrence of hepatocellular carcinoma by regulating B7-H1/PD-1 pathway through miRNA-570[D]. Guangzhou: Guangzhou University of Chinese Medicine,2017. |